Showing 1 - 9 results of 9 for search 'Amir Hashemi-Meshkini', query time: 0.04s Refine Results
  1. 1
    Making the Public Health and Industrial Objectives Balanced; the Big Challenge of Iran's Food and Drug Organization.

    Making the Public Health and Industrial Objectives Balanced; the Big Challenge of Iran's Food and Drug Organization. by Amir Hashemi-Meshkini

    Published 2014-05-01
    Get full text
    Article
  2. 2
    Evaluation of COVID-19 treatments in Iran in comparison with local therapeutic recommendations: A population-level study on utilization and costs of prescription drugs

    Evaluation of COVID-19 treatments in Iran in comparison with local therapeutic recommendations: A population-level study on utilization and costs of prescription drugs by Amir Hashemi-Meshkini, Reza Koochak, Shekoufeh Nikfar, Ehsan Rezaei-Darzi, Saeed Yaghoubifard

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Determinants and economic burden of HIV/AIDS in Iran: a prospective study

    Determinants and economic burden of HIV/AIDS in Iran: a prospective study by Tahmineh Reshadat-Hajiabad, Alireza Khajavi, Ali Mohammad Hosseinpour, Amin Bojdy, Amir Hashemi-Meshkini, Mehdi Varmaghani

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Developing a patient satisfaction questionnaire for services provided in Iranian community pharmacies

    Developing a patient satisfaction questionnaire for services provided in Iranian community pharmacies by Saeed Yaghoubifard, Arash Rashidian, Abbas Kebriaeezadeh, Ali Sheidaei, Mehdi Varmaghani, Amir Hashemi-Meshkini, Hedieh-Sadat Zekri

    Published 2016-01-01
    Get full text
    Article
  5. 5
    From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?

    From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies? by Amir Hashemi-Meshkini, Mehdi Varmaghani, Mehdi Yousefi, Saeed Yaghoubifard, Hedieh-Sadat Zekri, Shekoufeh Nikfar, Abbas Kebriaeezadeh

    Published 2014-01-01
    Get full text
    Article
  6. 6
    Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran

    Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran by Amir Hashemi-meshkini, Amirmohammad Tajik, Nayyereh Ayati, Shekoufeh Nikfar, Reza Koochak, Saeed Yaghoubifard, Azam Abbasi, Mehdi Varmaghani

    Published 2023-04-01
    Get full text
    Article
  7. 7
    Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis

    Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis by Zahra Goudarzi, Mehrdad Mostafavi, Mahmood Salesi, Mojtaba Jafari, Iman Mirian, Amir Hashemi Meshkini, Khosro Keshavarz, Younes Ghasemi

    Published 2023-01-01
    Get full text
    Article
  8. 8
    Pharmaceutical laws and regulations in Iran: An overview

    Pharmaceutical laws and regulations in Iran: An overview by Pardis Zaboli, Amir Hashemi-Meshkini, Mehdi Varmaghani, Hadi Gholami, Iman Vazirian, Hedieh-Sadat Zekri, Shahriar Eslamitabar, Abbas Kebriaeezadeh

    Published 2016-01-01
    Get full text
    Article
  9. 9
    Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis

    Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis by Mehdi Varmaghani, Amir Hashemi Meshkini, Farshad Farzadfar, Mehdi Yousefi, Saeed Yaghoubifard, Vida Varahrami, Ehsan Rezaei Darzi, Majid Anabi, Abbas Kebriaeezadeh, Hedieh-Sadat Zekri

    Published 2015-01-01
    Get full text
    Article

Search Tools: